Mast Group Introduces New MAST CARBA PAcE for Rapid Carbapenemase Detection

Mast Group Ltd. (Liverpool, UK) was amongst the 4,500 exhibitors from 70 countries that presented their products and services at the MEDICA 2019 Trade Fair held in Düsseldorf, Germany from 18-21st November. MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care. The combination of product shows with international congresses, forums, as well as expert workshops, and the exchange of professional views make MEDICA a meeting point for international professionals from various fields in the medical sector.

Mast is a manufacturer and supplier of diagnostic products for clinical, industrial and veterinary testing. The company manufactures microbiology and molecular biology products, as well as other infectious disease and autoimmune diagnostics, using a variety of technologies. At the 2019 edition of MEDICA, Mast introduced the new MAST CARBA PAcE for rapid carbapenemase detection in Pseudomonas spp., Acinetobacter spp. and Enterobacterales.


The company’s MAST ASSURE and CRYOBANK range also featured on the booth this year alongside its extensive range of MASTDISCS for antimicrobial susceptibility and resistance marker testing. MAST ASSURE’s extensive range contains both polyvalent and monovalent diagnostic antisera for the identification of Salmonella spp according to the expression of somatic antigens. Bacterial serotype can be determined by both slide agglutination and test tube agglutination methods.

The company’s MASTDISCS AST is available as an extensive range of antibiotic susceptibility test discs. Mast also offers an extensive range of MASTDISCS Combi antibiotic resistance detection sets for identification and differentiation of enzyme types using a combination disc technology, incorporating specific inhibitors to accurately detect extended spectrum ß-lactamase (ESßL), AmpC cephalosporinase, Metallo ß-lactamase (MBL) including VIM, IMP and NDM Klebsiella pneumoniae carbapenemase (KPC) and OXA-48 like carbapenemases.

Related Links:
Mast Group Ltd.